1. Involvement of heme oxygenase-1 induction in the cytoprotective and neuroinflammatory activities of Siegesbeckia Pubescens isolated from 5,3′-dihydroxy-3,7,4′-trimethoxyflavone in HT22 cells and BV2 cells
- Author
-
Sang Hyun Sung, Mina Lee, Gil Saeng Jeong, and Dong-Sung Lee
- Subjects
0301 basic medicine ,Programmed cell death ,Cell Survival ,NF-E2-Related Factor 2 ,p38 mitogen-activated protein kinases ,Immunology ,Asteraceae ,Pharmacology ,medicine.disease_cause ,Neuroprotection ,Dinoprostone ,Cell Line ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Animals ,Immunology and Allergy ,Medicine ,Flavonoids ,Neurons ,chemistry.chemical_classification ,Reactive oxygen species ,biology ,Tumor Necrosis Factor-alpha ,business.industry ,Membrane Proteins ,Heme oxygenase ,Nitric oxide synthase ,Neuroprotective Agents ,030104 developmental biology ,chemistry ,Biochemistry ,Cytoprotection ,Flavanones ,biology.protein ,Microglia ,Cyclooxygenase ,Reactive Oxygen Species ,business ,Heme Oxygenase-1 ,030217 neurology & neurosurgery ,Oxidative stress - Abstract
Glutamate-induced oxidative injury contributes to neuronal degeneration such as Alzheimer's disease, Parkinson's disease and Huntington's disease in the central nervous system (CNS). Siegesbeckia pubescens is used in oriental medicine to treat arthritis, stroke, rash, edema, and skin itching eczema in South-East Asia. This study provides evidence that 5,3'-dihydroxy-3,7,4'-trimethoxyflavone (DTMF), a compound isolated from 90% MeOH extract of Siegesbeckia pubescens, effectively has neuroprotective and anti-neuroinflammatory activities. DTMF has cytoprotective and reactive oxygen species (ROS) reductive effects in HT22 cells. DTMF also decreased LPS-induced inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2) expression but attenuated LPS-induced nitrite (NO) and prostaglandin E2 (PGE2), as well as TNF-α and IL-1β production. In addition, DTMF induced Heme oxygenase (HO)-1 expression, HO activity, nuclear transcription factor erythroid-2 related factor 2 (Nrf2) nuclear translocation, and antioxidant response element (ARE)-luciferase activity. DTMF increased p38 phosphorylation in HT22 cells and JNK phosphorylation in BV2 microglia cells. Thus, p38 inhibitor (SB203580) in HT22 cells and JNK inhibitor (SP600125) in BV2 microglia cells significantly suppressed HO-1 expression by DTMF. Furthermore, treatment with SnPP (an inhibitor of HO activity) significantly blocked the cytoprotective effects and the anti-neuroinflammatory action of DTMF. In addition, activated microglia-mediated cell death of mouse hippocampal HT22 cells was significantly repressed by DTMF. We also investigated the protective effect of DTMF on the death of glutamate-induced primary mouse hippocampal neurons. These results demonstrated that DTMF may be a good therapeutic agent against neurodegenerative diseases induced by oxidative stress.
- Published
- 2016
- Full Text
- View/download PDF